Tipranavir

Nat Rev Drug Discov. 2005 Dec;4(12):955-6. doi: 10.1038/nrd1907.
No abstract available

MeSH terms

  • Administration, Oral
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Approval
  • Drug Therapy, Combination
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors* / economics
  • HIV Protease Inhibitors* / pharmacology
  • HIV Protease Inhibitors* / therapeutic use
  • HIV-1 / drug effects
  • Humans
  • Pyridines* / economics
  • Pyridines* / pharmacology
  • Pyridines* / therapeutic use
  • Pyrones* / economics
  • Pyrones* / pharmacology
  • Pyrones* / therapeutic use
  • Randomized Controlled Trials as Topic
  • Ritonavir / administration & dosage
  • Sulfonamides
  • Time Factors
  • Treatment Outcome

Substances

  • HIV Protease Inhibitors
  • Pyridines
  • Pyrones
  • Sulfonamides
  • Ritonavir
  • tipranavir